Statistics about Health, Pharma & Medtech in United States
Statistics
- Praxis Precision Medicines operating profit 2019-2023
- Immix Biopharma liabilities 2020-2023
- Sibannac gross profit 2012-2016
- Impel Pharmaceuticals liabilities 2020-2022
- Ikena Oncology liabilities 2020-2023
- Igc Pharma, Inc. liabilities 2019-2023
- Igm Biosciences liabilities 2019-2023
- Ideaya Biosciences liabilities 2019-2023
- Infinity Pharmaceuticals operating profit 2018-2022
- Sibannac revenue 2012-2016
- Immuneering operating profit 2020-2023
- Senti Biosciences revenue 2021-2023
- Insmed operating profit 2019-2023
- Integrated Biopharma Inc operating profit 2020-2024
- Impel Pharmaceuticals operating profit 2020-2022
- Galectin Therapeutics Inc liabilities 2019-2023
- Galectin Therapeutics Inc total equity 2019-2023
- Immunic operating profit 2019-2023
- Immix Biopharma operating profit 2020-2023
- Ikena Oncology revenue 2020-2023
- Guardant Health total equity 2019-2023
- Icosavax, Inc. revenue 2020-2022
- Icosavax, Inc. liabilities 2020-2022
- Icosavax, Inc. total assets 2020-2022
- Genufood Energy Enzymes total assets 2019-2023
- Intercept Pharmaceuticals liabilities 2018-2022
- Intercept Pharmaceuticals net cash 2018-2022
- Genufood Energy Enzymes total equity 2019-2023
- Icosavax, Inc. net cash 2020-2022
- Intercept Pharmaceuticals operating profit 2018-2022
- Q Biomed net income 2015-2019
- Genufood Energy Enzymes operating profit 2019-2023
- Intercept Pharmaceuticals total assets 2018-2022
- Icosavax, Inc. operating profit 2020-2022
- Genufood Energy Enzymes net cash 2019-2023
- Genufood Energy Enzymes net income 2013-2021
- Genufood Energy Enzymes liabilities 2011-2013
- Genufood Energy Enzymes gross profit 2011-2013
- Intercept Pharmaceuticals revenue 2018-2022
- Intercept Pharmaceuticals net income 2018-2022
- Icosavax, Inc. net income 2020-2022
- Pyxis Oncology net income 2020-2023
- Prophase Labs revenue 2019-2023
- Icosavax, Inc. total equity 2019-2022
- Sensei Biotherapeutics net income 2020-2023
- Impel Pharmaceuticals net income 2020-2022
- Protagonist Therapeutics revenue 2019-2023
- Immunic net income 2013-2017
- Sibannac net income 2014-2015
- Poseida Therapeutics revenue 2021-2023
- Guardant Health total assets 2019-2023
- Guardant Health net cash 2019-2023
- Igm Biosciences net income 2019-2023
- In8Bio net income 2020-2023
- Ikena Oncology net income 2020-2023
- Intercept Pharmaceuticals total equity 2018-2022
- Immix Biopharma net income 2021-2023
- Guardant Health liabilities 2019-2023
- Guardant Health net income 2019-2023
- Imago Biosciences, Inc. net income 2020-2021
- Guardant Health operating profit 2019-2023
- Igc Pharma, Inc. net income 2019-2023
- Ideaya Biosciences net income 2019-2023
- Guardant Health revenue 2019-2023
- Provention Bio, Inc. revenue 2021-2022
- Hillevax total assets 2021-2023
- Generation Bio operating profit 2019-2023
- Infinity Pharmaceuticals liabilities 2018-2022
- Eli Lilly total assets 2019-2023
- Quest Diagnostics gross profit 2016-2020
- Silo Pharma, Inc. net income 2011-2021
- Harrow gross profit 2019-2023
- Sigilon Therapeutics net income 2020-2022
- Regeneron Pharmaceuticals total assets 2019-2023
- Regeneron Pharmaceuticals revenue 2019-2023
- Zoetis total assets 2019-2023
- Scopus Biopharma total equity 2018-2022
- Biogen total assets 2019-2023
- Healthy Extracts Inc. gross profit 2019-2023
- American Clean Resources Group net income 2019-2023
- Sana Biotechnology total equity 2019-2023
- Finch Therapeutics Group net cash 2020-2023
- Finch Therapeutics Group total equity 2019-2023
- Finch Therapeutics Group total assets 2020-2023
- Finch Therapeutics Group liabilities 2020-2023
- Finch Therapeutics Group operating profit 2020-2023
- Finch Therapeutics Group revenue 2020-2023
- Forma Therapeutics Holdings, Inc. total assets 2019-2021
- Quest Diagnostics net income 2019-2023
- Heska Corp gross profit 2018-2022
- Forma Therapeutics Holdings, Inc. net income 2019-2021
- Q32 Bio Inc. revenue 2019-2023
- Heska Corp liabilities 2018-2022
- Hst Global liabilities 2019-2023
- Q32 Bio Inc. total assets 2019-2023
- Q32 Bio Inc. liabilities 2019-2023
- Q32 Bio Inc. operating profit 2019-2023
- Quest Diagnostics total assets 2019-2023
- Q32 Bio Inc. total equity 2019-2023
- Harrow liabilities 2019-2023